BCYC insider transaction filings
BICYCLE THERAPEUTICS PLC — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen BCYC transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Perry Jennifer Scott — Chief Operating Officer | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Thompson Travis Alvin — Chief Financial Officer | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Skynner Michael — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Perry Jennifer Scott — Chief Operating Officer | Sale (S): 1,036 @ $4.27 · Sale (S): 43 @ $4.31 · Sale (S): 333 @ $4.34 | EDGAR |
| 2026-07-07 | 4 | Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF | Sale (S): 1,506 @ $4.27 · Sale (S): 255 @ $4.31 | EDGAR |
| 2026-07-07 | 4 | Thompson Travis Alvin — Chief Financial Officer | Sale (S): 819 @ $4.27 · Sale (S): 104 @ $4.31 | EDGAR |
| 2026-07-07 | 4 | Lee Kevin — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 5,905 @ $4.27 · Sale (S): 1,737 @ $4.31 | EDGAR |
| 2026-07-07 | 4 | Skynner Michael — CHIEF SCIENTIFIC OFFICER | Sale (S): 1,859 @ $4.27 · Sale (S): 532 @ $4.31 | EDGAR |
| 2026-04-06 | 4 | Perry Jennifer Scott — Chief Operating Officer | Sale (S): 1,038 @ $4.91 · Sale (S): 37 @ $5.05 · Sale (S): 333 @ $5.04 | EDGAR |
| 2026-04-06 | 4 | Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF | Sale (S): 1,521 @ $4.91 · Sale (S): 251 @ $5.05 | EDGAR |
| 2026-04-06 | 4 | Thompson Travis Alvin — Chief Financial Officer | Sale (S): 799 @ $4.91 · Sale (S): 102 @ $5.05 | EDGAR |
| 2026-04-06 | 4 | Lee Kevin — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 5,967 @ $4.91 · Sale (S): 1,716 @ $5.05 | EDGAR |
| 2026-04-06 | 4 | Skynner Michael — CHIEF SCIENTIFIC OFFICER | Sale (S): 1,879 @ $4.91 · Sale (S): 525 @ $5.05 | EDGAR |
| 2026-02-04 | 4 | Thompson Travis Alvin — Chief Financial Officer | Grant/award (A): 58,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Swanton Robert Charles — Director | Grant/award (A): 3,726 @ $0 · Grant/award (A): 7,453 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF | Grant/award (A): 50,000 @ $0 · Sale (S): 2,827 @ $6.80 · Sale (S): 2,367 @ $6.45 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Thompson Travis Alvin — CHIEF ACCOUNTING OFFICER | Grant/award (A): 37,500 @ $0 · Sale (S): 1,317 @ $6.80 · Sale (S): 1,115 @ $6.45 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Young Alethia — Chief Financial Officer | Grant/award (A): 50,000 @ $0 · Sale (S): 3,289 @ $6.80 · Sale (S): 2,456 @ $6.45 · Sale (S): 1,878 @ $6.54 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Sands Stephen H. — Director | Grant/award (A): 9,500 @ $0 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Milnes Alistair — CHIEF OPERATING OFFICER | Grant/award (A): 50,000 @ $0 · Sale (S): 3,244 @ $6.80 · Sale (S): 3,416 @ $6.46 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Riva Alessandro — Director | Grant/award (A): 7,380 @ $0 · Grant/award (A): 14,761 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Bourque Janice — Director | Grant/award (A): 9,500 @ $0 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Winter Gregory Paul — Director | Grant/award (A): 9,500 @ $0 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Lee Kevin — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 165,000 @ $0 · Sale (S): 10,325 @ $6.80 · Sale (S): 10,989 @ $6.46 · Grant/award (A): 330,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Skynner Michael — CHIEF TECHNOLOGY OFFICER | Grant/award (A): 50,000 @ $0 · Sale (S): 3,045 @ $6.80 · Sale (S): 3,266 @ $6.46 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | DANSEY ROGER D — Director | Grant/award (A): 3,032 @ $0 · Grant/award (A): 6,065 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Gutierrez-Ramos Jose-Carlos — Director | Grant/award (A): 9,500 @ $0 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Hoppenot Herve — Director | Grant/award (A): 3,032 @ $0 · Grant/award (A): 6,065 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | BAKER BROS. ADVISORS LP — Director, 10% owner 667, L.P. — Director, 10% owner Baker Bros. Advisors (GP) LLC — Director, 10% owner Baker Brothers Life Sciences LP — Director, 10% owner BAKER FELIX — Director, 10% owner BAKER JULIAN — Director, 10% owner | Grant/award (A): 19,000 @ $0 · Grant/award (A): 19,000 @ $0 · Grant/award (A): 38,000 (derivative) @ $0 · Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2025-10-06 | 4 | Swanton Robert Charles — Director | Sale (S): 102 @ $8.55 | EDGAR |
| 2025-10-06 | 4 | Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF | Sale (S): 473 @ $8.40 · Sale (S): 250 @ $8.41 | EDGAR |
| 2025-10-06 | 4 | Thompson Travis Alvin — CHIEF ACCOUNTING OFFICER | Sale (S): 221 @ $8.40 · Sale (S): 103 @ $8.41 | EDGAR |
| 2025-10-06 | 4 | Young Alethia — Chief Financial Officer | Sale (S): 217 @ $8.40 · Sale (S): 265 @ $8.61 | EDGAR |
| 2025-10-06 | 4 | Milnes Alistair — CHIEF OPERATING OFFICER | Sale (S): 1,147 @ $8.40 · Sale (S): 978 @ $8.41 | EDGAR |
| 2025-10-06 | 4 | Lee Kevin — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 2,263 @ $8.40 · Sale (S): 3,231 @ $8.41 | EDGAR |
| 2025-10-06 | 4 | Skynner Michael — CHIEF TECHNOLOGY OFFICER | Sale (S): 824 @ $8.40 · Sale (S): 978 @ $8.41 | EDGAR |
| 2025-09-10 | 4 | DANSEY ROGER D — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Hoppenot Herve — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Swanton Robert Charles — Director | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-07-07 | 4 | Lee Kevin — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 2,268 @ $7.09 · Sale (S): 3,193 @ $7.44 | EDGAR |
| 2025-07-07 | 4 | Skynner Michael — CHIEF TECHNOLOGY OFFICER | Sale (S): 825 @ $7.09 · Sale (S): 966 @ $7.44 | EDGAR |
| 2025-07-07 | 4 | Milnes Alistair — CHIEF OPERATING OFFICER | Sale (S): 1,149 @ $7.09 · Sale (S): 966 @ $7.44 | EDGAR |
| 2025-07-07 | 4 | Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF | Sale (S): 474 @ $7.09 · Sale (S): 248 @ $7.44 | EDGAR |
| 2025-07-07 | 4 | Thompson Travis Alvin — CHIEF ACCOUNTING OFFICER | Sale (S): 206 @ $7.09 · Sale (S): 100 @ $7.44 | EDGAR |
| 2025-07-07 | 4 | Young Alethia — Chief Financial Officer | Sale (S): 204 @ $7.09 | EDGAR |
| 2025-04-04 | 4 | Young Alethia — Chief Financial Officer | Sale (S): 215 @ $8.02 | EDGAR |
| 2025-04-04 | 4 | Skynner Michael — CHIEF TECHNOLOGY OFFICER | Sale (S): 814 @ $8.02 · Sale (S): 1,038 @ $7.48 | EDGAR |
| 2025-04-04 | 4 | Lee Kevin — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 2,237 @ $8.02 · Sale (S): 3,432 @ $7.48 | EDGAR |
| 2025-04-04 | 4 | Milnes Alistair — CHIEF OPERATING OFFICER | Sale (S): 1,133 @ $8.02 · Sale (S): 1,038 @ $7.48 | EDGAR |
Recent 8-K events — BICYCLE THERAPEUTICS PLC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BCYC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →